Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors - PubMed (original) (raw)
Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors
Y Inoue et al. Ann Surg. 1993 Sep.
Abstract
Objective: Arginine transport was characterized and studied in human liver.
Summary background data: Plasma arginine uptake may regulate hepatocyte intracellular availability and the subsequent biosynthesis of nitric oxide (NO), but little is known about arginine transport across the human hepatocyte plasma membrane.
Methods: The authors characterized plasma membrane transport of 3[H]-L-arginine in hepatic plasma membrane vesicles (HPMVs) and in hepatocytes isolated and cultured from human liver biopsy specimens. They also studied the effects of the NO synthase inhibitors omega-nitro-L-arginine methyl ester (L-NAME) and N-methyl-arginine (NMA) on arginine transport in HPMVs and in cultured cells.
Results: Arginine transport was saturable, Na(+)-independent, temperature and pH sensitive, and was inhibited by the naturally occurring amino acids lysine, homoarginine, and ornithine (System y+ substrates). Arginine transport by both vesicles and cultured hepatocytes was significantly attenuated by NO synthase inhibitors, suggesting that the arginine transporter and the NO synthase enzyme may share a structurally similar arginine binding site. Dixon plot analysis showed the blockade to occur by competitive, rather than noncompetitive, inhibition. In vivo treatment of rats with lipopolysaccharide (LPS) resulted in a twofold stimulation of saturable arginine transport in the liver. This LPS-induced hepatic arginine transport activity was also inhibited by L-NAME. These data indicate that arginine transport by human hepatocytes is mediated primarily by the Na(+)-independent transport System y+.
Conclusions: Besides inhibition of the NO synthase enzyme, the ability of arginine derivatives to block NO production may also be due to their ability to competitively inhibit arginine transport across the hepatocyte plasma membrane. The use of selective arginine derivatives that compete with arginine at the plasma membrane level may be a metabolic strategy that can be used to modulate the septic response.
Similar articles
- Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
Bogle RG, Moncada S, Pearson JD, Mann GE. Bogle RG, et al. Br J Pharmacol. 1992 Apr;105(4):768-70. doi: 10.1111/j.1476-5381.1992.tb09053.x. Br J Pharmacol. 1992. PMID: 1380372 Free PMC article. - Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
Baydoun AR, Mann GE. Baydoun AR, et al. Biochem Biophys Res Commun. 1994 Apr 29;200(2):726-31. doi: 10.1006/bbrc.1994.1511. Biochem Biophys Res Commun. 1994. PMID: 7513994 - Two unique aspects of inducible .N = O synthase in liver cells and accessory cells: hepatic damage is minimized by hepatocyte .N = O production and immunoregulation is mediated by macrophage .N = O production.
Billiar TR, Langrehr JM, Curran RD, Ochoa JB, Stadler J, Harbrecht BG, Hoffman RA, Simmons RL. Billiar TR, et al. Res Immunol. 1991 Sep;142(7):584-6; discussion 598-9. doi: 10.1016/0923-2494(91)90108-u. Res Immunol. 1991. PMID: 1725933 Review. No abstract available. - Biomarkers of arginine and lysine excess.
Luiking YC, Deutz NE. Luiking YC, et al. J Nutr. 2007 Jun;137(6 Suppl 2):1662S-1668S. doi: 10.1093/jn/137.6.1662S. J Nutr. 2007. PMID: 17513444 Review.
Cited by
- Nitric oxide and chronic HCV and HIV infections.
Lake-Bakaar G, Sorbi D, Mazzoccoli V. Lake-Bakaar G, et al. Dig Dis Sci. 2001 May;46(5):1072-6. doi: 10.1023/a:1010770230422. Dig Dis Sci. 2001. PMID: 11341651 - Chronic effects of two rutile TiO2 nanomaterials in human intestinal and hepatic cell lines.
Jalili P, Krause BC, Lanceleur R, Burel A, Jungnickel H, Lampen A, Laux P, Luch A, Fessard V, Hogeveen K. Jalili P, et al. Part Fibre Toxicol. 2022 May 17;19(1):37. doi: 10.1186/s12989-022-00470-1. Part Fibre Toxicol. 2022. PMID: 35578293 Free PMC article. - Transport of L-Arginine Related Cardiovascular Risk Markers.
Banjarnahor S, Rodionov RN, König J, Maas R. Banjarnahor S, et al. J Clin Med. 2020 Dec 8;9(12):3975. doi: 10.3390/jcm9123975. J Clin Med. 2020. PMID: 33302555 Free PMC article. Review. - Nitric oxide. Novel biology with clinical relevance.
Billiar TR. Billiar TR. Ann Surg. 1995 Apr;221(4):339-49. doi: 10.1097/00000658-199504000-00003. Ann Surg. 1995. PMID: 7537035 Free PMC article. Review. - Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide.
Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, Billiar TR. Liu S, et al. Infect Immun. 2002 Jul;70(7):3433-42. doi: 10.1128/IAI.70.7.3433-3442.2002. Infect Immun. 2002. PMID: 12065483 Free PMC article.
References
- Anal Biochem. 1976 Jan;70(1):241-50 - PubMed
- Biochemistry. 1979 Apr 17;18(8):1525-30 - PubMed
- Ann N Y Acad Sci. 1980;349:57-66 - PubMed
- J Biol Chem. 1985 Oct 5;260(22):12118-23 - PubMed
- Biochim Biophys Acta. 1985 Dec 9;822(3-4):355-74 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources